These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2459936)

  • 41. Kinetic mechanism and substrate specificity of glutathione peroxidase activity of ebselen (PZ51).
    Maiorino M; Roveri A; Coassin M; Ursini F
    Biochem Pharmacol; 1988 Jun; 37(11):2267-71. PubMed ID: 3377822
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preventive effect of ebselen on acute gastric mucosal lesion development in rats treated with compound 48/80.
    Kobayashi T; Ohta Y; Yoshino J
    Eur J Pharmacol; 2001 Mar; 414(2-3):271-9. PubMed ID: 11239928
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A novel biologically active seleno-organic compound--I. Glutathione peroxidase-like activity in vitro and antioxidant capacity of PZ 51 (Ebselen).
    Müller A; Cadenas E; Graf P; Sies H
    Biochem Pharmacol; 1984 Oct; 33(20):3235-9. PubMed ID: 6487370
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ebselen, a useful tool for understanding cellular redox biology and a promising drug candidate for use in human diseases.
    Noguchi N
    Arch Biochem Biophys; 2016 Apr; 595():109-12. PubMed ID: 27095225
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ebselen affects calcium homeostasis in human platelets.
    Brüne B; Diewald B; Ullrich V
    Biochem Pharmacol; 1991 Jun; 41(12):1805-11. PubMed ID: 2039537
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The early research and development of ebselen.
    Parnham MJ; Sies H
    Biochem Pharmacol; 2013 Nov; 86(9):1248-53. PubMed ID: 24012716
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential effects of ebselen on neutrophil recruitment, chemokine, and inflammatory mediator expression in a rat model of lipopolysaccharide-induced pulmonary inflammation.
    Haddad el-B; McCluskie K; Birrell MA; Dabrowski D; Pecoraro M; Underwood S; Chen B; De Sanctis GT; Webber SE; Foster ML; Belvisi MG
    J Immunol; 2002 Jul; 169(2):974-82. PubMed ID: 12097404
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ebselen-binding equilibria between plasma and target proteins.
    Ullrich V; Weber P; Meisch F; von Appen F
    Biochem Pharmacol; 1996 Jul; 52(1):15-9. PubMed ID: 8678900
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Induction of cellular necrosis by the glutathione peroxidase mimetic ebselen.
    Guérin PJ; Gauthier ER
    J Cell Biochem; 2003 May; 89(1):203-11. PubMed ID: 12682920
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effects of ebselen on cisplatin and diethyldithiocarbamate (DDC) cytotoxicity in rat hippocampal astrocytes.
    Hardej D; Trombetta LD
    Toxicol Lett; 2002 May; 131(3):215-26. PubMed ID: 11992741
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Strong inhibition of mammalian lipoxygenases by the antiinflammatory seleno-organic compound ebselen in the absence of glutathione.
    Schewe C; Schewe T; Wendel A
    Biochem Pharmacol; 1994 Jul; 48(1):65-74. PubMed ID: 8043032
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The selenoorganic compound ebselen suppresses liver injury induced by Propionibacterium acnes and lipopolysaccharide in rats.
    Koyanagi T; Nakamuta M; Enjoji M; Iwamoto H; Motomura K; Sakai H; Nawata H
    Int J Mol Med; 2001 Mar; 7(3):321-7. PubMed ID: 11179515
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of ebselen (PZ51) on ischaemic brain oedema after focal ischaemia in cats.
    Johshita H; Sasaki T; Matsui T; Hanamura T; Masayasu H; Asano T; Takakura K
    Acta Neurochir Suppl (Wien); 1990; 51():239-41. PubMed ID: 2089906
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Oral pretreatment with ebselen enhances heat shock protein 72 expression and reduces myocardial infarct size.
    Baljinnyam E; Hasebe N; Morihira M; Sumitomo K; Matsusaka T; Fujino T; Fukuzawa J; Ushikubi F; Kikuchi K
    Hypertens Res; 2006 Nov; 29(11):905-13. PubMed ID: 17345791
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Elimination of plasma phosphatidylcholine hydroperoxide by a seleno-organic compound, Ebselen.
    Miyazawa T; Suzuki T; Fujimoto K; Kinoshita M
    J Biochem; 1993 Oct; 114(4):588-91. PubMed ID: 8276773
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interaction of albumin-bound ebselen with rat liver glutathione S-transferase and microsomal proteins.
    Nikawa T; Schuch G; Wagner G; Sies H
    Biochem Mol Biol Int; 1994 Feb; 32(2):291-8. PubMed ID: 8019434
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ebselen protects mice against T cell-dependent, TNF-mediated apoptotic liver injury.
    Tiegs G; Küsters S; Künstle G; Hentze H; Kiemer AK; Wendel A
    J Pharmacol Exp Ther; 1998 Dec; 287(3):1098-104. PubMed ID: 9864298
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ebselen has dehydroascorbate reductase and thioltransferase-like activities.
    Jung CH; Washburn MP; Wells WW
    Biochem Biophys Res Commun; 2002 Mar; 291(3):550-3. PubMed ID: 11855823
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transport of ebselen in plasma and its transfer to binding sites in the hepatocyte.
    Wagner G; Schuch G; Akerboom TP; Sies H
    Biochem Pharmacol; 1994 Sep; 48(6):1137-44. PubMed ID: 7945407
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Biological activities and clinical potential of Ebselen.
    Parnham MJ
    Adv Exp Med Biol; 1990; 264():193-7. PubMed ID: 2244495
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.